| Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous Leishmaniasis (NCT05708625) | Zagazig University | 2022-01-01 |
| Evaluation of the Safety and Clinical Activity of Curaleish in the Topical Treatment of Cutaneous Leishmaniasis. (NCT04072874) | Universidad de Antioquia | 2021-01-01 |
| Investigation of an Outbreak Situation of Cutaneous Leishmaniasis Among Military Personnel in French Guiana (CEFELEISH) (NCT04888130) | Centre Hospitalier de Cayenne | 2020-12-01 |
| A Clinical Study to Develop an Uninfected Sand Fly Biting Protocol (NCT03999970) | University of York | 2019-10-03 |
| Evaluation of a Diagnostic Device, CL Detect™ Rapid Test, for the Diagnosis of Cutaneous Leishmaniasis in Peru (NCT03762070) | Naval Medical Research Center | 2018-10-02 |
| ASYMPTOMATIC CARRIER OF LEISHMANIA INFANTUM, MEDISERRANEAN VISCERAL LEISHMANIOSIS AGENT: STUDY OF IMMUNE RESPONSE - (NCT03303898) | Centre Hospitalier Universitaire de Nice | 2017-11-10 |
| Topical Paromomycin for Cutaneous Leishmaniasis in Bolivia (NCT03096457) | Fundacion Nacional de Dermatologia | 2017-04-15 |
| A Study of a New Leishmania Vaccine Candidate ChAd63-KH (NCT02894008) | University of York | 2016-11-01 |
| Miltefosine Plus IL Pentamidine for Bolivian CL (NCT03445897) | Jonathan Berman | 2016-01-31 |
| Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis (NCT03294161) | Hospital Universitário Professor Edgard Santos | 2014-12-01 |
| Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis (NCT01140191) | U.S. Army Medical Research and Development Command | 2013-09-01 |
| Development of Topical Herbal Formulations for Treatment of Cutaneous Leishmaniasis (NCT04841239) | Jinnah Sindh Medical University | 2012-01-01 |
| Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama (NCT01083576) | U.S. Army Medical Research and Development Command | 2010-03-01 |
| Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) (NCT01032382) | U.S. Army Medical Research and Development Command | 2010-01-01 |
| Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis (NCT00469495) | Hospital Universitário Professor Edgard Santos | 2007-02-01 |
| Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis (NCT00111553) | Access to Advanced Health Institute (AAHI) | 2004-10-01 |
| Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis (NCT01641796) | U.S. Army Medical Research and Development Command | |
| Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis (NCT00508963) | University of California, San Francisco | |